Towards targeted drugs and next generation of nanomedicines

• Anna Salvati,
• Silvia Giordani and
• Wolfgang J. Parak

Beilstein J. Nanotechnol. 2026, 17, 598–601, doi:10.3762/bjnano.17.41

• Anna Salvati Silvia Giordani Wolfgang J. Parak University of Groningen, Groningen Research Institute of Pharmacy, Groningen, The Netherlands School of Chemical Sciences, Dublin City University, Glasnevin, Dublin, Ireland Center for Hybrid Nanostructures (CHyN), University of Hamburg, Hamburg

• this be possible, the nanomedicines would reach the next step of maturity. Anna Salvati, Silvia Giordani, and Wolfgang J. Parak Groningen, Dublin, and Hamburg, March 2026

Antibody-conjugated nanoparticles for target-specific drug delivery of chemotherapeutics

• Mamta Kumari,
• Amitabha Acharya and
• Praveen Thaggikuppe Krishnamurthy

Beilstein J. Nanotechnol. 2023, 14, 912–926, doi:10.3762/bjnano.14.75

• -containing media, which confirmed protein corona formation. The protein corona establishes a barrier between the ligand and the target, significantly reducing the NP targeting efficiency as compared to bare NPs [79]. Salvati et al. developed transferrin (Tf)-modified fluorescent silica NPs to evaluate the

Interactions at the cell membrane and pathways of internalization of nano-sized materials for nanomedicine

• Valentina Francia,
• Daphne Montizaan and
• Anna Salvati

Beilstein J. Nanotechnol. 2020, 11, 338–353, doi:10.3762/bjnano.11.25

• Valentina Francia Daphne Montizaan Anna Salvati Groningen Research Institute of Pharmacy, University of Groningen, 9713AV Groningen, Netherlands 10.3762/bjnano.11.25 Abstract Nano-sized materials have great potential as drug carriers for nanomedicine applications. Thanks to their size, they can

Low uptake of silica nanoparticles in Caco-2 intestinal epithelial barriers

• Dong Ye,
• Mattia Bramini,
• Delyan R. Hristov,
• Sha Wan,
• Anna Salvati,
• Christoffer Åberg and
• Kenneth A. Dawson

Beilstein J. Nanotechnol. 2017, 8, 1396–1406, doi:10.3762/bjnano.8.141

• Dong Ye Mattia Bramini Delyan R. Hristov Sha Wan Anna Salvati Christoffer Aberg Kenneth A. Dawson Centre for BioNano Interactions, School of Chemistry and Chemical Biology, University College Dublin, Belfield, Dublin 4, Ireland present address: AbbVie Deutschland GmbH & Co KG, Brain Delivery at

Protein corona – from molecular adsorption to physiological complexity

• Lennart Treuel,
• Dominic Docter,
• Michael Maskos and
• Roland H. Stauber

Beilstein J. Nanotechnol. 2015, 6, 857–873, doi:10.3762/bjnano.6.88

• an HSA or transferrin corona both reduced the amount of endocytosed NPs with the exact causes for this behavior remaining uncertain. Also focusing on the transferrin corona, Salvati, Dawson and co-workers were able to demonstrate how transferrin-functionalized NPs can lose their targeting